World

Pfizer to co-produce Coronavirus Drug Remdesivir

Two competitors in the pharmaceutical industry are working together in the fight against SARS-CoV-2 and the disease that can cause it, COVID-19. On Friday, Pfizer (NYSE: PFE) announced that it had struck a deal with Gilead Sciences (NASDAQ: VALID) to produce the brake derivative of the latter. In May, the …

Read More »